Mycenax Biotech Market Cap

Mycenax Biotech has a market cap or net worth of 8.09 billion as of June 27, 2025. Its market cap has decreased by -11.26% in one year.

Market Cap

8.09B

Enterprise Value

8.81B

Revenue

725.45M

Ranking

n/a

PE Ratio

n/a

Stock Price

39.05

Market Cap Chart

Since October 31, 2008, Mycenax Biotech's market cap has increased from 584.10M to 8.09B, an increase of 1,284.64%. That is a compound annual growth rate of 17.08%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	8.09B	-9.81%
Dec 31, 2024	8.97B	22.00%
Dec 29, 2023	7.35B	-4.53%
Dec 30, 2022	7.70B	32.48%
Dec 30, 2021	5.81B	40.74%
Dec 31, 2020	4.13B	38.50%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Caliway Biopharmaceuticals	207.06B
PharmaEssentia	182.30B
Bora Pharmaceuticals Co., LTD.	84.51B
Lotus Pharmaceutical	57.58B
Oneness Biotech	30.80B
Polaris Group	30.05B
Center Laboratories	27.10B
Lumosa Therapeutics	25.58B

Market Cap Rankings